IBI3033

· Innovent Biologics (Suzhou) Co. Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IBI3033, covering 2025-12-30 to 2026-04-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of IBI3033 in Moderate-to-Severe Atopic Dermatitis [Phase 1]